Loading
CH
Cano Health, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Gold Lewis, was filed 21 Mar 2022.
Cano Health, Inc.: what insiders have been doing
This page follows insider dealings at Cano Health, Inc. as filed with SEC (Form 4), a company from the Healthcare & Pharma sector. The past year has been quiet: not a single insider filing for Cano Health, Inc. The previous disclosure was published on 2 July 2024.
Looking back to 2021, when coverage begins, insiders filed 22 purchases and 38 sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
172
Thresholds
n/a
Buy Volume
€17M
22 ops. · all time
Sell Volume
€6M
38 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2023FY ended December 2023 · cache
Income statement
RevenueUS$2.7B
Net income-US$511.8M-18.9% margin
Last declaration on 2 July 2024
Declarations172 total
9,557,095 sharesCommon StockSEC:0000905148-24-001836:1
555,508 sharesCommon StockSEC:0000905148-24-001836:2
45,995 sharesClass A Common StockSEC:0000950170-24-080518:1
23,609 sharesClass A Common StockSEC:0000950170-24-080518:2
23,609 sharesClass A Common StockSEC:0000950170-24-080518:3
1,749 sharesClass A Common StockSEC:0000950170-24-080518:4
1,749 sharesClass A Common StockSEC:0000950170-24-080518:5
3,782 sharesClass A Common StockSEC:0000950170-24-080498:1
2,485 sharesClass A Common StockSEC:0000950170-24-080502:1
6,641 sharesClass A Common StockSEC:0000950170-24-080510:0
7,676 sharesClass A Common StockSEC:0000950170-24-080520:0
912,538 sharesCommon StockSEC:0000905148-24-001836:0
2,485 sharesClass A Common StockSEC:0000950170-24-080511:0
269,586 sharesClass A Common StockSEC:0000950170-24-080508:0
2,485 sharesClass A Common StockSEC:0000950170-24-080493:0
15,296 sharesClass A Common StockSEC:0000950170-24-080518:0
69,685 sharesClass A Common StockSEC:0000950170-24-080502:0
136,804 sharesClass A Common StockSEC:0000950170-24-080498:0
8,935 shares@ US$2.5940.6% of flowClass A Common StockSEC:0000950170-24-010089:1
1,100 shares@ US$2.52770.1% of flowClass A Common StockSEC:0000950170-24-010089:2
12,703 shares@ US$2.6991.7% of flowClass A Common StockSEC:0000950170-24-010089:0
32,693 shares@ US$2.74482.3% of flowClass A Common StockSEC:0000950170-24-008484:1
41,357 shares@ US$2.74372.9% of flowClass A Common StockSEC:0000950170-24-008484:2
18,569 shares@ US$2.58282.4% of flowClass A Common StockSEC:0000950170-24-008484:0
125,000 shares@ US$2.502115.5% of flowClass A Common StockSEC:0000950170-24-007152:0
25 of 172 declarations
About Cano Health, Inc.
Cano Health, Inc. is a U.S.-based healthcare company focused on primary care for seniors and, more broadly, for populations covered through publicly funded or value-based reimbursement models. The company is listed on the U.S. NYSE/NASDAQ market and operates in the United States, with its corporate headquarters in Miami, Florida. Founded in 2009, Cano Health built its business around a value-based care framework designed to improve clinical outcomes while lowering the total cost of care. In practical terms, that means the company emphasizes preventive care, chronic-disease management, and coordinated treatment pathways rather than relying only on episodic physician visits.
Cano Health’s core offering centers on primary care delivered through a network of medical centers, supported by wellness programs and ancillary services available at select locations. The company describes its model as patient-centered and geared toward helping members navigate the healthcare system more effectively. This is especially relevant in the senior segment, where utilization is higher, care needs are more complex, and continuity of care can materially influence both outcomes and costs. From an investor perspective, Cano Health’s business mix is aligned with recurring revenue characteristics, since a meaningful portion of reimbursement is tied to ongoing member relationships and contracted payer arrangements rather than one-off procedures.
Read moreShow less
In competitive terms, Cano Health operates in a crowded and highly regulated U.S. healthcare landscape. It competes with other primary care groups, managed-care-oriented providers, and larger integrated healthcare platforms. Its differentiation has historically come from dense local market coverage, a strong focus on seniors, and a care model that seeks to capture savings through better coordination and earlier intervention. That said, the company has also faced significant financial and operational stress in recent years, which makes execution and balance-sheet normalization central to the investment case.
Geographically, Cano Health remains concentrated primarily in Florida, with historical activity in other U.S. markets and Puerto Rico. This regional footprint is important: it suggests operational expertise in selected markets rather than nationwide scale. Recent company developments have been shaped by a major restructuring process initiated in 2024, which fundamentally altered the capital structure and remains a key reference point for the stock. More recently, the company’s disclosures and corporate communications indicate an ongoing effort to stabilize operations and restore long-term performance.
For French-speaking investors, Cano Health is best viewed as a specialized U.S. healthcare provider with exposure to demographic tailwinds, but also with elevated restructuring risk and a need for disciplined execution. The combination of a senior-focused care model, regional density, and a value-based reimbursement strategy gives the company strategic relevance, while its recent corporate history keeps the risk profile above that of a standard defensive healthcare name.
